Nasdaq
CRSP
CRISPR Therapeutics AG
- Health Care
- Switzerland
- Listed 2016
- 1 day
- −1.5%
- 1 month
- −15.0%
- 1 year
- −8.3%
$51.64 · Mkt cap $4.99B
At the 6 Aug 2026 close
Nasdaq
CRISPR Therapeutics AG
$51.64 · Mkt cap $4.99B
At the 6 Aug 2026 close
CRISPR Therapeutics AG trades under the ticker CRSP on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2016. Its market capitalisation is $4.99B. The last closing price was $51.64, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −8.3%, and −15.0% over the past month. Returns are price returns and exclude dividends.
This page exists because CRSP is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.